Laryngotracheal Recurrent Papillomatosis: A Case Study and Survey of Surgical and Systemic Management-Reference-Cited by-同舟云学术

Laryngotracheal Recurrent Papillomatosis: A Case Study and Survey of Surgical and Systemic Management

Published:2022-09-29 Issue:10_suppl Volume:101 Page:47S-51S
ISSN:0145-5613
Container-title:Ear, Nose & Throat Journal
language:en
Short-container-title:Ear Nose Throat J

Author:

Borrelli Michela¹²^ORCID,Nasrollahi Tasha¹²³,Raskin Jonathan¹²⁴^ORCID,Khan Sana⁵,Alexander Ronda E¹⁶

Affiliation:

1. Cedars Sinai Sinus Center of Excellence, Los Angeles, CA, USA

2. Cedars-Sinai Division of Otolaryngology, Los Angeles, CA, USA

3. California Northstate University College of Medicine, Elk Grove, CA, USA

4. Oakland University William Beaumont School of Medicine, Detroit, MI, USA

5. American University of Antigua College of Medicine, Osbourn, AN, USA

6. Montefiore Medical Center, Bronx, NY, USA

Abstract

This case report presents a 72-year-old man with longstanding recurrent respiratory papillomatosis (RRP). He has undergone multiple procedures for the condition, including an apparent urgent surgical airway followed by tracheoplasty repair. Modern management of complicated RRP should include both local debulking and systemic approaches. Systemic bevacizumab (Avastin) has shown some initial success as an effective treatment option, in addition to other medications such as pembrolizumab. Other future care strategies may include an HPV vaccination and other adjuvants; vaccination has been reported to have the possibility of drastically reducing the incidence of RRP.

Publisher

SAGE Publications

Subject

Otorhinolaryngology

Link

http://journals.sagepub.com/doi/pdf/10.1177/01455613221128714

Reference23 articles.

1. Systemic Bevacizumab (Avastin) for Juvenile‐Onset Recurrent Respiratory Papillomatosis: A Systematic Review

2. Ruiz R, Balamuth N, Javia LR, Zur KB. Systemic Bevacizumab Treatment for Recurrent Respiratory Papillomatosis: Long-Term Follow-Up, The Laryngoscope.

3. Stabilization of Recurrent Respiratory Papillomatosis with Pembrolizumab Therapy: A Case Report

4. Prevention of recurrent respiratory papillomatosis: Role of HPV vaccination

5. Risk Factors for Dysplasia in Recurrent Respiratory Papillomatosis in an Adult and Pediatric Population